Senomyx Seeks Alternatives To “Spoonful Of Sugar” To Make Meds Go Down
This article was originally published in The Tan Sheet
Executive Summary
Senomyx expects to develop bitter flavor-blocking agents for use in pediatric OTC products in 2006, the biotechnology firm stated during a Jan. 12 presentation to investors
You may also be interested in...
Senomyx, Solae savory soy
A partnership by soy protein supplier Solae and flavor technology developer Senomyx aims to improve soy protein's taste through the development of bitter blockers. Since April 2007, scientists from both firms have collaborated to determine the bitter components of soy protein and discovered new ingredients to modulate how taste receptors respond, the companies say Sept. 15. Under a licensing agreement, Solae will retain exclusive worldwide rights to use the soy protein flavor ingredients in all food and beverages, with Senomyx receiving royalties based on sales. San Diego-based Senomyx previously sought bitter-blocking agents for use in OTC pediatric products (1"The Tan Sheet" Jan. 16, 2006, p. 13). St. Louis-based Solae once pursued a qualified health claim linking soy protein to cancer prevention, but withdrew its petition in 2005 (2"The Tan Sheet" Oct. 31, 2005, In Brief)
Senomyx, Solae savory soy
A partnership by soy protein supplier Solae and flavor technology developer Senomyx aims to improve soy protein's taste through the development of bitter blockers. Since April 2007, scientists from both firms have collaborated to determine the bitter components of soy protein and discovered new ingredients to modulate how taste receptors respond, the companies say Sept. 15. Under a licensing agreement, Solae will retain exclusive worldwide rights to use the soy protein flavor ingredients in all food and beverages, with Senomyx receiving royalties based on sales. San Diego-based Senomyx previously sought bitter-blocking agents for use in OTC pediatric products (1"The Tan Sheet" Jan. 16, 2006, p. 13). St. Louis-based Solae once pursued a qualified health claim linking soy protein to cancer prevention, but withdrew its petition in 2005 (2"The Tan Sheet" Oct. 31, 2005, In Brief)
Senomyx, Solae savory soy
A partnership by soy protein supplier Solae and flavor technology developer Senomyx aims to improve soy protein's taste through the development of bitter blockers. Since April 2007, scientists from both firms have collaborated to determine the bitter components of soy protein and discovered new ingredients to modulate how taste receptors respond, the companies say Sept. 15. Under a licensing agreement, Solae will retain exclusive worldwide rights to use the soy protein flavor ingredients in all food and beverages, with Senomyx receiving royalties based on sales. San Diego-based Senomyx previously sought bitter-blocking agents for use in OTC pediatric products (1"The Tan Sheet" Jan. 16, 2006, p. 13). St. Louis-based Solae once pursued a qualified health claim linking soy protein to cancer prevention, but withdrew its petition in 2005 (2"The Tan Sheet" Oct. 31, 2005, In Brief)